APP and Alzheimer disease: In 7-month-aged APP/PS1 mice with memory deficit, treatment with the polysaccharide fraction of A. membranaceous significantly improved the cognitive ability of APP/PS1 mice, lessened apoptosis and the accumulation of Aβ, which is highly characteristic in patients with Alzheimer’s disease (AD) [57].